Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients
- PMID: 2341582
- DOI: 10.1002/j.1552-4604.1990.tb03606.x
Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients
Abstract
Despite extensive clinical experience with azathioprine (AZA), the disposition of various AZA metabolites remains obscure. We therefore evaluated the pharmacokinetics of three AZA metabolites: 6-mercaptopurine (6-MP), the immediate metabolite; 6-thiouric acid (6-TU), the final end product; and 6-thioguanine nucleotides (TGN), the active moiety; in eight renal transplant patients after oral administration of AZA. The low peak plasma 6-MP level of 73.7 +/- 23.7 ng/mL (mean +/- SD) and the short half-life (t1/2) of 1.9 +/- 0.6 hours suggest rapid conversion of 6-MP to other metabolites. A peak plasma 6-TU concentration of 1210 +/- 785 ng/mL was observed at 3.5 +/- 0.6 hours after the AZA dose. The strong correlation between 6-TU t1/2 and serum creatinine (r = 0.98, P = .0008) supported our previous work showing that 6-TU is primarily excreted by the kidneys. The total TGN levels in red blood cells (RBCs) in each patient remained largely unchanged over 24 hours with the intraindividual coefficient of variation ranging from 4.4% to 29.8%. In comparison, the mean TGN level varied considerably between patients, and ranged from undetectable to 413 pmol per 8 X 10(8) RBCs. However, there was no apparent correlation between white cell counts on day 0 (P greater than .5), day 7 (P greater than .5), or day 14 (P greater than .5) and RBC TGN level. The persistence of TGN in body tissues thus provides a pharmacokinetic rationale for the conventional once or twice daily AZA regimen.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprine.Eur J Clin Pharmacol. 1989;36(3):265-71. doi: 10.1007/BF00558158. Eur J Clin Pharmacol. 1989. PMID: 2526020
-
Plasma concentrations and organ distribution of thiopurines after oral application of azathioprine in mice.Cancer Chemother Pharmacol. 1991;28(1):7-14. doi: 10.1007/BF00684949. Cancer Chemother Pharmacol. 1991. PMID: 2040036
-
Kinetics of mercaptopurine and thioguanine nucleotides in renal transplant recipients during azathioprine treatment.Ther Drug Monit. 1994 Feb;16(1):13-20. doi: 10.1097/00007691-199402000-00002. Ther Drug Monit. 1994. PMID: 8160249
-
Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease.Ther Drug Monit. 2017 Dec;39(6):584-588. doi: 10.1097/FTD.0000000000000455. Ther Drug Monit. 2017. PMID: 29040228 Free PMC article. Review.
-
The therapeutic use of azathioprine in renal transplantation.Pharmacotherapy. 1987;7(5):165-77. doi: 10.1002/j.1875-9114.1987.tb04046.x. Pharmacotherapy. 1987. PMID: 3324057 Review.
Cited by
-
Clinical pharmacology of inflammatory bowel disease therapies.Curr Gastroenterol Rep. 2000 Dec;2(6):440-5. doi: 10.1007/s11894-000-0005-0. Curr Gastroenterol Rep. 2000. PMID: 11079044 Review.
-
Role of exclusive enteral nutrition in the preoperative optimization of patients with Crohn's disease following immunosuppressive therapy.Medicine (Baltimore). 2015 Feb;94(5):e478. doi: 10.1097/MD.0000000000000478. Medicine (Baltimore). 2015. PMID: 25654387 Free PMC article.
-
Autoantibody-negative autoimmune hepatitis.Dig Dis Sci. 2012 Mar;57(3):610-24. doi: 10.1007/s10620-011-2017-z. Epub 2011 Dec 21. Dig Dis Sci. 2012. PMID: 22187100 Review.
-
Clinical pharmacology and pharmacogenetics of thiopurines.Eur J Clin Pharmacol. 2008 Aug;64(8):753-67. doi: 10.1007/s00228-008-0478-6. Epub 2008 May 28. Eur J Clin Pharmacol. 2008. PMID: 18506437 Review.
-
Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.Clin Pharmacokinet. 2007;46(3):187-208. doi: 10.2165/00003088-200746030-00001. Clin Pharmacokinet. 2007. PMID: 17328579 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous